Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vaccines After COVID: Catch-Up Watch Under Way

Executive Summary

There has been a dramatic drop-off in routine immunization rates in the US and around the world amid the COVID-19 outbreak. The catch-up effort may complicate the pandemic response efforts.

You may also be interested in...



COVID-19 Vaccine Safety: National Academy Of Medicine Could Add Layer Of Oversight

Merck's Gerberding notes that NAM has previously monitored safety of childhood vaccines and could help build confidence in one for COVID-19. The former CDC director's suggestion gets a bipartisan endorsement at a US Senate committee hearing.

Turning Vaccine Priority Upside Down: Applying H1N1 Lessons To COVID-19

A successful COVID-19 vaccine candidate will create a critical challenge: who receives the first doses of what is bound to be a constrained supply? Vaccine developers see useful lessons from the 2009 H1N1 outbreak – but a very different priority order.

Too Many Generals? The Potential Downside Of ‘Operation Warp Speed’

A Manhattan Project-style campaign to accelerate COVID-19 treatments could help end the pandemic. But it also brings another set of layers – and yet a new group of leaders – into an already complex network.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS142426

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel